Overview

Addition of Tobramycin Inhalation in the Treatment of Ventilator Associated Pneumonia

Status:
Completed
Trial end date:
2020-07-01
Target enrollment:
Participant gender:
Summary
This study evaluates the addition of tobramycin inhalation treatment to standard intravenous therapy in the treatment of ventilator associated pneumonia.
Phase:
Phase 4
Details
Lead Sponsor:
Erasmus Medical Center
Collaborator:
Chiesi Farmaceutici S.p.A.
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Tobramycin